Retrieved By Health eConsultation / Friday, December 1, 2017 / Categories: Medications FDA Approves 'Biosimilar' Drug Ogivri for Breast, Stomach Cancers Source: HealthDayLink to original article Previous Article New Migraine Drugs Show Promise Next Article Once-Monthly Injection Approved for Opioid Addiction Print 2720 Rate this article: No rating 0Upvote 0Downvote Please login or register to post comments.